Keith Lindor

13PUBLICATIONS
57CO-AUTHORS
ChemotherapyPredictive and prognostic markersContract lawPacific Peoples biomedical and clinical scienceMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

David E J Jones, Ulrich Beuers, Alan Bonder

|May 09, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.

C Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally

|Jan 27, 2023
Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis.

Ahmad H Ali, Cynthia W Buness, Ryan Fischer

|Sep 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.

Rozanne C de Veer, Maren H Harms, Christophe Corpechot

|Dec 24, 2021
Machine learning in primary biliary cholangitis: A novel approach for risk stratification.

Alessio Gerussi, Damiano Verda, Davide Paolo Bernasconi

|Jul 05, 2021
Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysis.

Tej I Mehta, Simcha Weissman, Brian M Fung

Pageof 3